FDA grants speedy approval to Eli Lilly weight-loss pill

The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug manufacturer announced on Tuesday that the company would begin shipping orforglipron, branded as Foundayo, as soon as Monday following approval from federal regulators. Prescribed as a…

FDA grants speedy approval to Eli Lilly weight-loss pill

Chemicals in plastics linked to newborn deaths, premature births: Research

Trump’s surgeon general nominee caught in GOP crossfire over MAHA

admin

Trump's surgeon general nominee caught in GOP crossfire over MAHA

Americans die younger in states with conservative policies: study

US bans foreign travelers from Ebola-impacted nations

Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

HHS withdraws amended vaccine advisory panel charter

CDC elevates Ebola response to highest level

Health Care — Draft Supreme Court opinion sets off uproar

UN calls reproductive rights ‘foundation’ of equality for women and girls

57 percent in new poll want Supreme Court to support abortion rights

CDC elevates Ebola response to highest level

Sanders releases trove of internal HHS emails showing RFK Jr. pressured CDC over vaccine messaging

Flu cases at Texas base hit 275 as services again require recruits to get shots

Trump administration plans to deport more than 500 migrant children within days, senator warns

Recent News

CDC elevates Ebola response to highest level

Sanders releases trove of internal HHS emails showing RFK Jr. pressured CDC over vaccine messaging

Flu cases at Texas base hit 275 as services again require recruits to get shots

Trump administration plans to deport more than 500 migrant children within days, senator warns